Flemiclav 625 Tablet is a potent antibiotic formulation combining Amoxycillin 500mg and Clavulanic Acid 125mg, designed to effectively combat a wide range of bacterial infections. Amoxycillin, a broad-spectrum penicillin antibiotic, works by inhibiting the synthesis of bacterial cell walls, leading to the destruction of susceptible bacteria. However, some bacteria produce beta-lactamase enzymes that can inactivate amoxycillin, reducing its efficacy. Clavulanic Acid acts as a beta-lactamase inhibitor, protecting amoxycillin from enzymatic degradation and thereby extending its antibacterial spectrum. Flemiclav 625 is commonly prescribed for respiratory tract infections, urinary tract infections, skin and soft tissue infections, and dental infections caused by beta-lactamase-producing bacteria. It is also effective against sinusitis, otitis media, and certain gastrointestinal infections. The combination ensures enhanced efficacy against resistant bacterial strains, promoting faster recovery. Patients should take Flemiclav 625 as directed by a healthcare professional, typically with food to minimize gastrointestinal discomfort. It is important to complete the full course to prevent resistance development. Common side effects may include mild gastrointestinal disturbances such as nausea, diarrhea, or rash. This medication is contraindicated in individuals with penicillin allergy. Always consult a healthcare provider before use to ensure safety and appropriateness.